The Manufacturer and User Facility Device Experience (MAUDE) database was queried for contemporary BPH treatments.  The MAUDE adverse event classification system was used to standardize complications.  Only 18 (0.7%) patients required medical/surgical management (MAUDE II-IV) due to a device complication.  Of note, great care should be taken with morcellator use during HoLEP as it had the greatest number of MAUDE II to IV complications among all devices. 
MAUDE